The Controversy Around Pharmacy Benefit Managers

This episode is brought to you by Semafor Healthcare.Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.Listen to Health Affairs' Leslie Erdelack and Marianne Amoss discuss the recent antitrust lawsuit against Express Scripts and Prime Therapeutics regarding pharmacy benefit managers and alleged collusion to share drug pricing information.Join us for a Lunch and Learn Event on Health Care Workforces on April 4. This event is supported by the de Beaumont Foundation.Related Links:Pharmacy Benefit Managers and Their Role in Drug Spending (The Commonwealth Fund)The Association Between Drug Rebates and List Prices (University of Southern California)Ohio Attorney General David Yost Files Suit Against Express Scripts, Prime Therapeutics Over Rising Drug Costs (FierceHealthcare)Podcast: Pharmacy Benefit Managers, the FTC & You (Health Affairs This Week)Health Policy Brief: Pharmacy Benefit Managers (Health Affairs)Currently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone. Subscribe to Semafor Healthcare for free.